Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research... Show more
A.I.dvisor indicates that over the last year, SOPH has been loosely correlated with TEM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SOPH jumps, then TEM could also see price increases.
| Ticker / NAME | Correlation To SOPH | 1D Price Change % | ||
|---|---|---|---|---|
| SOPH | 100% | +4.94% | ||
| TEM - SOPH | 44% Loosely correlated | -4.62% | ||
| SDGR - SOPH | 38% Loosely correlated | -2.94% | ||
| RIOT - SOPH | 32% Poorly correlated | +2.38% | ||
| COIN - SOPH | 30% Poorly correlated | -2.92% | ||
| MNDR - SOPH | 29% Poorly correlated | -4.05% | ||
More | ||||
| Ticker / NAME | Correlation To SOPH | 1D Price Change % |
|---|---|---|
| SOPH | 100% | +4.94% |
| Services to the Health Industry industry (42 stocks) | 28% Poorly correlated | +0.34% |
| Health Services industry (239 stocks) | 3% Poorly correlated | +0.37% |
Industry ServicestotheHealthIndustry
SOPH saw its Momentum Indicator move above the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 119 similar instances where the indicator turned positive. In 110 of the 119 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SOPH's RSI Oscillator exited the oversold zone, 17 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for SOPH just turned positive on November 09, 2026. Looking at past instances where SOPH's MACD turned positive, the stock continued to rise in 49 of 53 cases over the following month. The odds of a continued upward trend are 90%.
SOPH moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +10.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOPH advanced for three days, in 205 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
SOPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for SOPH crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for SOPH entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.313) is normal, around the industry mean (4.477). P/E Ratio (-6.155) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (6.452) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. SOPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.